Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
May 6, 2020
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCS from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
May 6, 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams’ Role Expanded to Chairman and CEO
May 6, 2020
Rachael Alford, PhD Joins RallyBio to Lead CMC Operations
April 30, 2020
Pear Therapeutics to Release Pear-004 to Help People Living with Schizophrenia During the COVID-19 Crisis
April 8, 2020
Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer
April 7, 2020
Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer
March 26, 2020
Pear Therapeutics Obtains FDA Authorization for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults With Chronic Insomnia
March 26, 2020
Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics
March 18, 2020
IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations
March 18, 2020
IDEAYA Biosciences Announces IDE196 Monotherapy Phase 2 Does Selection and Clinical Program Update
« Previous Page
1
…
57
58
59
60
61
…
119
Next Page »